Pentokey Organy (India) Ltd
Pentokey Organy (India) Ltd Live Price Chart
Performance
| Previous Close | ₹ 33.02 |
| High | ₹ 32.5 |
| Volume | 282 |
| 52W Range | ₹ 28.49 - ₹ 57 |
| Open | ₹ 32.5 |
| Low | ₹ 32.5 |
| Market Cap | ₹ 20.26 Cr |
Pentokey Organy (India) Ltd Technicals
| 20 Day | ₹ 33.580 |
| 50 Day | ₹ 34.331 |
| 100 Day | ₹ 35.626 |
| 200 Day | ₹ 37.808 |
| 20 Day | ₹ 33.332 |
| 50 Day | ₹ 34.220 |
| 100 Day | ₹ 36.396 |
| 200 Day | ₹ 37.941 |
Pentokey Organy (India) Ltd Fundamentals
| ROCE | 2.556 |
| P/E Ratio | 75.580 |
| P/B Ratio | 2.100 |
| Industry P/E | 2.100 |
| Debt to Equity | 51.671 |
| ROE | 2.532 |
| EPS | 0.430 |
| Dividend Yield | 0.000 |
| Book Value | 15.459 |
| Face Value | 10.000 |
Pentokey Organy (India) Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 2.4979 | 1.2905 | 4.8477 | 6.7215 | 0.2519 |
| Total Expenses | 2.2949 | 1.045 | 3.9723 | 3.546 | 0.4154 |
| Profit After Tax | 0.203 | 0.2455 | 0.8754 | 3.1755 | -0.1635 |
Pentokey Organy (India) Ltd Shareholding Pattern
| Promoter Holdings | 73.035 % |
| FIIs | 0.000 % |
| DIIs | 2.245 % |
| MutualFund | 0.064 % |
| Retail | 16.274 % |
| Others - | 8.383 % |
About Pentokey Organy (India) Ltd
Pentokey Organy (India) Limited was incorporated on November 26, 1986. The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde. Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices. Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde. As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low. Acetaldehyde was produced only to the extent of demand from customers. Further, Company could source Ethanol from various distilleries at competitive prices due to improved production of Sugar and Ethanol within the State of Maharashtra and so, it increased production capacity to 24000 TPA from 18000 TPA. During the period 2025, Company has amended the object clause by addition of additional clause in the object engaging into the trading activities of fertilizers and pesticides with due approval from the Registrar of Companies effective June 16, 2025. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 40.15 -0.98 (-2.38%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 506.00 -4.9 (-0.96%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,517.85 -71.05 (-1.08%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 709.00 +23.1 (+3.37%) |
| Abbott India Ltd Pharmaceuticals | ₹ 27,000.00 +88.25 (+0.33%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,397.20 -6.8 (-0.48%) |
FAQs on Pentokey Organy (India) Ltd
1. Can I buy Pentokey Organy (India) Ltd from PL Capital? ›
2. Does Pentokey Organy (India) Ltd pay dividends? ›
3. What is the current share price of Pentokey Organy (India) Ltd ? ›
4. What is the 52-week high and low of Pentokey Organy (India) Ltd ? ›
5. What is the market capitalisation of Pentokey Organy (India) Ltd? ›
6. What is the current P/E ratio of Pentokey Organy (India) Ltd? ›
7. What is the current P/B ratio of Pentokey Organy (India) Ltd? ›
8. What is the shareholding pattern of Pentokey Organy (India) Ltd? ›
9. What is the 1-year return of Pentokey Organy (India) Ltd? ›
Start SIP in Pentokey Organy (India) Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
